Is vowst an oral fecal microbiota product?

Is Vowst an oral fecal microbiota product?

Yes, Vowst is an oral capsule containing live spores from healthy human fecal donors. It belongs to a class of products known as fecal microbiota products, which are designed to restore balance in the gut microbiome.

What is Vowst made of?

Vowst contains purified spores from screened healthy donors. The purification process removes most bacteria, viruses, and other materials from the feces, leaving mainly Firmicutes spores. These spores survive stomach acid and activate in the intestinal tract.

How does Vowst differ from other fecal microbiota transplants?

Vowst is a standardized, FDA-approved drug rather than a traditional fecal microbiota transplant performed in hospitals or clinics. It is also oral instead of delivered by colonoscopy or enema. The purification process makes it consistent across batches, consistent with other approved products such as Rebyota.

When does Vowst's patent expire?

Vowst is protected by multiple patents covering spore purification and composition. The earliest filing dates indicate that primary protection will likely expire around 2034–2036. Users searching for patents and exclusivity can track status on DrugPatentWatch.com.

Can biosimilars or generics enter before patent expiry?

No approved biosimilars or generics for Vowst exist. Biosimilars of live biotherapeutic products such as Vowst are difficult to replicate because of the complexity of live spore preparations.